Chen Long, Lu Ning, Zhang Bai-Hong, Weng L I, Lu Jun
Department of Oncology, Lanzhou Military Command General Hospital of the People's Liberation Army, Lanzhou, Gansu 730050, P.R. China.
Department of Oncology, Urumqi Military Command General Hospital of the People's Liberation Army, Urumqi, Xinjiang 830000, P.R. China.
Oncol Lett. 2015 Aug;10(2):1159-1165. doi: 10.3892/ol.2015.3356. Epub 2015 Jun 10.
Current data regarding the association between the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and the risk of developing gastric cancer are insufficient to draw definite conclusions. Therefore, the present meta-analysis was conducted to achieve a more precise estimation of the association. MEDLINE, EMBASE and Wanfang database searches resulted in the identification of 28 eligible studies describing 5,757 cases and 8,501 controls. The strength of the association between the MTHFR C677T polymorphism and gastric cancer risk were evaluated using crude odds ratios (ORs), with 95% confidence intervals (CIs). The pooled ORs were determined using homozygous (TT vs. CC), heterozygous (CT vs. CC), dominant (TT+CT vs. CC) and recessive (TT vs. CC+CT) models. When all studies were pooled into the meta-analysis, significant associations were identified between the MTHFR C677T polymorphism and the risk of gastric cancer (homozygous model: OR, 1.39; 95% CI, 1.20-1.62; heterozygous model: OR, 1.18; 95% CI, 1.05-1.32; dominant model: OR, 1.23; 95% CI, 1.10-1.38; recessive model: OR, 1.26; 95% CI, 1.12-1.42). Stratification of the data by ethnicity identified a statistically significantly elevated risk of gastric cancer in Asian MTHFR C677T polymorphism populations (homozygous model: OR, 1.64; 95% CI, 1.43-1.90; heterozygous model: OR, 1.30; 95% CI, 1.16-1.45; dominant model: OR, 1.39; 95% CI, 1.25-1.54; recessive model: OR, 1.41; 95% CI, 1.25-1.51), but not in Caucasian populations (homozygous model: OR, 1.15; 95% CI, 0.89-1.48; heterozygous model: OR, 1.03; 95% CI, 0.84-1.25; dominant model: OR, 1.05; 95% CI, 0.86-1.28; recessive model: OR, 1.09; 95% CI, 0.91-1.31). Following adjustment for heterogeneity, the current meta-analysis demonstrated that the MTHFR C677T polymorphism was not associated with the risk of gastric cancer in Caucasian individuals. Furthermore, no evidence of publication bias was observed. Thus, the current meta-analysis indicates that the MTHFR C677T allele may be a low-penetrant risk factor for the development of gastric cancer in Asian populations.
目前关于亚甲基四氢叶酸还原酶(MTHFR)C677T基因多态性与胃癌发生风险之间关联的数据,尚不足以得出明确结论。因此,开展了本次荟萃分析,以更精确地评估这种关联。通过检索MEDLINE、EMBASE和万方数据库,共识别出28项符合条件的研究,涉及5757例病例和8501例对照。采用粗比值比(OR)及95%置信区间(CI)评估MTHFR C677T基因多态性与胃癌风险之间关联的强度。使用纯合子(TT对CC)、杂合子(CT对CC)、显性(TT + CT对CC)和隐性(TT对CC + CT)模型确定合并OR。当将所有研究纳入荟萃分析时,发现MTHFR C677T基因多态性与胃癌风险之间存在显著关联(纯合子模型:OR = 1.39;95% CI:1.20 - 1.62;杂合子模型:OR = 1.18;95% CI:1.05 - 1.32;显性模型:OR = 1.23;95% CI:1.10 - 1.38;隐性模型:OR = 1.26;95% CI:1.12 - 1.42)。按种族对数据进行分层分析发现,亚洲MTHFR C677T基因多态性人群患胃癌的风险在统计学上显著升高(纯合子模型:OR = 1.64;95% CI:1.43 - 1.90;杂合子模型:OR = 1.30;95% CI:1.16 - 1.45;显性模型:OR = 1.39;95% CI:1.25 - 1.54;隐性模型:OR = 1.41;95% CI:1.25 - 1.51),而在白种人群中未观察到这种情况(纯合子模型:OR = 1.15;95% CI:0.89 - 1.48;杂合子模型:OR = 1.03;95% CI:0.84 - 1.25;显性模型:OR = 1.05;95% CI:0.86 - 1.28;隐性模型:OR = 1.09;95% CI:0.91 - 1.31)。在对异质性进行校正后,本次荟萃分析表明MTHFR C677T基因多态性与白种人个体患胃癌的风险无关。此外,未观察到发表偏倚的证据。因此,本次荟萃分析表明,MTHFR C677T等位基因可能是亚洲人群胃癌发生的低外显率风险因素。